Drs. Davis, Lieb and Rathmell, all members of UNC Lineberger, are featured in an article on V's Voice, the blog for The V Foundation for Cancer Research.
The North Carolina Biotechnology Center recently awarded the Society for Translational Oncology (STO) $5,000 to be used for the organization's annual meeting. This year's meeting "Personalizing Cancer Diagnosis and Treatment 2012" will be held October 20-21 at UNC Lineberger.
Andrew Wang, MD, assistant professor of radiation oncology, has been awarded a $50,000 one-year grant from the Lung Cancer Research Foundation.
Chapel Hill, NC – Christophe Guilluy, PhD, Wenjin Liu, PhD and JinZhu Duan, PhD are the first, second, and third place recipients of the Joseph S. Pagano Award for a paper by a postdoctoral fellow published in 2011.
WCHL named UNC Lineberger director Shelley Earp, MD, the Village Pride Award Honoree for October 2, 2012. Each weekday the station selects a Hometown Hero who goes “over and above the call of duty,” exemplifying excellent service and dedication to others in the community.
Chapel Hill, NC – More than 50 Chapel Hill and Carrboro businesses and community groups are turning the towns pink during the months of September and October to raise funds for UNC Lineberger Comprehensive Cancer Center and its Comprehensive Cancer Support Program.
New research from UNC has established the first link between the two most fundamental epigenetic tags -- histone modification and DNA methylation -- in humans.
DALLAS -- An American clinician-scientist and an Israeli researcher whose work has led to more personalized treatments for breast cancer are being honored as this year’s winners of the prestigious Susan G. Komen for the Cure® Brinker Awards for Scientific Distinction in Basic Science and Clinical Research, the highest awards of merit given by the world’s leading breast cancer organization.
Blossom Damania, PhD, and Dirk Dittmer, PhD, both have lived all over the world, where they saw firsthand the global burden of cancer. Both are professors of microbiology and immunology in the UNC school of Medicine and members of UNC Lineberger.
James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, provided his perspective on a HuffPost Live broadcast that aired on September 24, 2012.
Team identifies genetic causes and similarity to ovarian cancer
Carey named Division Chief of Hematology-Oncology and Physician-in-Chief of the N.C. Cancer Hospital
Chapel Hill - Lisa A. Carey, MD, has been appointed Chief of the Division of Hematology and Oncology at the University of North Carolina School of Medicine and Physician-in-Chief of the N.C. Cancer Hospital.
Chapel Hill, NC – The cost of sequencing the entire human genome, or exome – the regions of the genome that are translated into proteins that affect cell behavior – has decreased significantly, to the point where the cost of looking at the majority of a patient’s genomic data may be less expensive than undertaking one or two targeted genetic tests.
James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, is quoted in NPR's second story in its "$1,000 Genome" series, which aired today.
Chapel Hill, NC –Researchers have long known that individual diseases are associated with genes in specific locations of the genome.
Preclinical testing a necessary step in drug development
UNC Lineberger faculty co-author review article on adjuvant chemotherapy in women 70 years of age and older
Dr. Angelique Whitehurst, assistant professor of pharmacology, was awarded a 2011 Innovative Research Grant from Stand Up to Cancer, the scientific partner of the American Association of Cancer Research.
Chapel Hill, NC – A mysterious form of cell death, coded in proteins and enzymes, led to a discovery by UNC researchers uncovering a prime suspect for new cancer drug development.
Changes in DNA that are important to the initiation and progression of lung cancer also identified by NIH-supported researchers